ArticleCancer immunology, immunotherapy : CII2013

The antitumor effect of the toll-like receptor 3 ligand polyinosinic-cytidylic acid as an adjuvant.

Yu-Kun Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.